Straits Times Index
3,313.35 +9.69 (+0.29%) S&P 500
5,246.68 +25.26 (+0.48%) Dow
39,558.11 +126.60 (+0.32%) Nasdaq
16,511.18 +122.94 (+0.75%) Bitcoin USD
61,617.81 -1,194.51 (-1.90%) CMC Crypto 200
1,268.86 -22.54 (-1.74%)
MDT Nov 2024 105.000 call
| Previous close | 0.1700 |
| Open | 0.2000 |
| Bid | 0.0800 |
| Ask | 0.3800 |
| Strike | 105.00 |
| Expiry date | 2024-11-15 |
| Day's range | 0.1700 - 0.2000 |
| Contract range | N/A |
| Volume | |
| Open interest | 6 |
BenzingaWill Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems Market
On Tuesday, Blue Orca Capital released a report on Insulet Corporation (NASDAQ:PODD), saying it is short on the insulin delivery patch pump manufacturer. The report added that Blue Orca is long on its upstart Korean competitor EOFlow Co Ltd as last week the Court of Appeals for the Federal Circuit killed a preliminary injunction that protected Insulet’s key monopoly against competition from EOFlow. The report adds that the injunction is undisclosed to investors. The report notes, “In our opinion
ZacksMedtronic (MDT) Advances While Market Declines: Some Information for Investors
In the closing of the recent trading day, Medtronic (MDT) stood at $83.52, denoting a +0.82% change from the preceding trading day.
Insider Monkey14 Best Long-Term Dividend Stocks To Buy Now
In this article, we discuss 14 best long-term dividend stocks to buy now. You can skip our detailed analysis of dividend stocks and their previous performance, and go directly to read 5 Best Long-Term Dividend Stocks To Buy Now. For long-term investing, many investors aim for not just growth but a steady stream of income […]
